Correlation Between Celcuity LLC and Lyell Immunopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Celcuity LLC and Lyell Immunopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Celcuity LLC and Lyell Immunopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Celcuity LLC and Lyell Immunopharma, you can compare the effects of market volatilities on Celcuity LLC and Lyell Immunopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Celcuity LLC with a short position of Lyell Immunopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Celcuity LLC and Lyell Immunopharma.

Diversification Opportunities for Celcuity LLC and Lyell Immunopharma

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between Celcuity and Lyell is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Celcuity LLC and Lyell Immunopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyell Immunopharma and Celcuity LLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Celcuity LLC are associated (or correlated) with Lyell Immunopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyell Immunopharma has no effect on the direction of Celcuity LLC i.e., Celcuity LLC and Lyell Immunopharma go up and down completely randomly.

Pair Corralation between Celcuity LLC and Lyell Immunopharma

Given the investment horizon of 90 days Celcuity LLC is expected to under-perform the Lyell Immunopharma. But the stock apears to be less risky and, when comparing its historical volatility, Celcuity LLC is 2.41 times less risky than Lyell Immunopharma. The stock trades about -0.14 of its potential returns per unit of risk. The Lyell Immunopharma is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  94.00  in Lyell Immunopharma on August 28, 2024 and sell it today you would lose (3.00) from holding Lyell Immunopharma or give up 3.19% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Celcuity LLC  vs.  Lyell Immunopharma

 Performance 
       Timeline  
Celcuity LLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Celcuity LLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Lyell Immunopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lyell Immunopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Celcuity LLC and Lyell Immunopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Celcuity LLC and Lyell Immunopharma

The main advantage of trading using opposite Celcuity LLC and Lyell Immunopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Celcuity LLC position performs unexpectedly, Lyell Immunopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyell Immunopharma will offset losses from the drop in Lyell Immunopharma's long position.
The idea behind Celcuity LLC and Lyell Immunopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation